A controlled clinical trial of ultraviolet blood irradiation (UVBI) for hepatitis C infection
The FDA Phase I controlled clinical trial results of ultraviolet blood irradiation (UVBI) to treat patients with hepatitis C Virus (HCV) infection are described in this report. This study was conducted prior to the availability of other highly effective therapies, e.g., the combination of ledipasvir...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Cogent Medicine |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/2331205X.2019.1614286 |